secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enovis CORP (ENOV)
CIK:        0001420800
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001420800-23-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enovis Q1 net sales $406M (+9% organic), adj EPS $0.44; raises FY2023 outlook
-----------------------------------------------------------------------------

- Recon segment organic growth 19% (P&R +4%); total organic sales +9%.
- Adjusted EBITDA $56M (13.9% of sales, +120 bps YoY); net loss from cont ops $0.42/sh.
- FY 2023 outlook raised: organic rev growth 6-7% (prev 5-6%), adj EBITDA $259-267M, adj EPS $2.18-2.32.
- Agreement to acquire Novastep (bunion segment) expected to close Q2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420800/000142080023000012/0001420800-23-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420800/000142080023000012/cfx-20230504.htm
  HTML page:      https://secwatch.observer/filing/0001420800-23-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer